From CPHI Milan: Three Quality Questions Peptide Buyers Keep Asking
An interview with Yara, Quality Director at Utide Following CPHI Milan 2026, we spoke with Yara, Utide’s Quality Director, about three questions that appear repeatedly in peptide buyer inquiries: Does the COA match the batch delivered? Can the results be independently verified? What stability information is available? Q: Why does the batch number matter […]
The Growing Demand for Peptide Manufacturing
Understanding how global peptide growth is reshaping expectations for scalable manufacturing, quality systems, and long-term supply partnerships. The global peptide industry is entering a new stage of growth. As peptide-based therapies, research programs, and advanced molecular platforms continue to expand, the demand for reliable peptide manufacturing is becoming stronger and more diverse. For global […]
Quality by Design in Peptide Manufacturing
Understanding how systematic quality control supports reliable, scalable peptide manufacturing. Peptide manufacturing is a highly technical process in which quality is shaped by every stage of production. From synthesis and cleavage to purification, salt conversion, lyophilization, and final release testing, each step can influence the final product profile. In this context, quality cannot be […]
From Peptide Discovery to Industrial Manufacturing
Understanding the transition from laboratory peptide synthesis to scalable, quality-driven manufacturing. Peptide innovation often begins in the laboratory, where a new sequence, modification, or therapeutic concept is first validated at a small scale. At this stage, the focus is usually on whether the peptide can be successfully synthesized, purified, and characterized. However, moving from […]